Jim Simons’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Jim Simons’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-28,700	Closed	-$2.77M	–	3826
2020 Q2	$2.77M	Sell	28,700 -21,400	-43%	-$1.79M	﹤0.01%	1989
2020 Q1	$2.35M	Buy	+50,100	New	+$3.21M	﹤0.01%	1970
2019 Q3	–	Sell	-123,500	Closed	-$6.19M	–	3839
2019 Q2	$6.19M	Buy	123,500 +11,700	+10%	+$570K	0.01%	1695
2019 Q1	$5.81M	Buy	+111,800	New	+$5.15M	0.01%	1703
2018 Q3	–	Sell	-37,400	Closed	-$1.86M	–	3652
2018 Q2	$1.86M	Sell	37,400 -89,000	-70%	-$4.31M	﹤0.01%	2296
2018 Q1	$6.17M	Sell	126,400 -125,400	-50%	-$6.52M	0.01%	1685
2017 Q4	$10.6M	Sell	251,800 -94,566	-27%	-$3.64M	0.01%	1344
2017 Q3	$14.8M	Buy	+346,366	New	+$11.1M	0.02%	1085
2016 Q4	–	Sell	-11,100	Closed	-$181K	–	3568
2016 Q3	$181K	Buy	+11,100	New	+$200K	﹤0.01%	3086

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Jim Simons's MYOK Position: Q3 2020 in Review

Jim Simons sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 28,700 shares — an estimated $2.77M sold.

Jim Simons first reported a position in MYOK in Q3 2016 and held it in 9 quarters. The position peaked at $14.8M in Q3 2017. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

Jim Simons reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Jim Simons sold 28,700 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $2.77M.
Jim Simons first reported a position in MyoKardia, Inc. Common Stock in Q3 2016 and held it in 9 quarters.
Jim Simons's MyoKardia, Inc. Common Stock position peaked at $14.8M in Q3 2017.
237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Renaissance Technologies's 13F filing for Q3 2020, filed 13 Nov 2020.